Legionella Testing Market: Global Market Size, Dynamics, Regional Share, Trends, Competitor Analysis 2017 to 2021 and Forecast 2022 to 2028

$ PRICE - $ 3,000.00$ 8,900.00

Legionella Testing Market: By Application Type (Water Testing, IVD Testing), By Product (Kits and Reagents), By Distribution Channel (Hospitals, Diagnostic Labs, Others), and Geography

 

$ PRICE - $ 3,000.00$ 8,900.00
Clear selection
Clear
$ PRICE - $ 3,000.00$ 8,900.00
FacebookTwitterLinkedinEmail

Report

Description

The legionella testing market is anticipated to be valued at USD 241.5 million in 2021 and is expanded to grow at a significant CAGR of 9.7% over 2022-2028. Legionella bacterial species are present in freshwater reservoirs and are responsible for legionnaire’s disease, a respiratory ailment. The market is anticipated to increase fast during the projected period due to the increased incidence and prevalence of this disease, pushing up demand for testing kits. Furthermore, the rising incidence of hospital-acquired legionella infection and increased testing frequency in these facilities due to stringent regulations will drive demand for such effective products in the near future. The presence of diverse species in water reservoirs like ponds, lakes, swimming pools, warm water showers, and commercial building water supply pipes is increasing health hazards. Exposure to legionellosis outbreaks increases the risk of morbidity and mortality. Thus, stringent monitoring of water reservoirs and the launch of rapid testing methods for onsite water testing are anticipated to promote Legionella testing market growth. In the Legionella Testing Market, the Urinary Antigen Test (UAT) Segment is Expected to Hold a Major Market Share. This test category is predicted to develop rapidly over the projection period due to distinct advantages such as detecting whole serogroups associated with legionella and quick testing. Due to the expensive cost of PCR procedures, their general application in the current economy is limited.

Recent Market Developments:

In December 2021, QUIDEL CORPORATION signs a definitive agreement to acquire ortho clinical diagnostics. Provides Quidel’s expansive point-of-care diagnostics portfolio with access to Ortho’s broad global reach across 130-plus countries, accelerating growth for Quidel’s existing product portfolio and providing exposure to new, emerging markets

In Feb 2019, bioMérieux, an in vitro diagnostics and food microbiology testing company, announced the acquisition of Invisible Sentinel. This newly acquired company, based in Philadelphia, develops, manufactures, and markets molecular diagnostic tools for the rapid, accurate and reliable detection of pathogens and spoilage organisms in food and beverage.

Legionella Testing Market

MARKET SUMMARY
-
8.6% CAGR
  • Study Period– 2021-2027
  • Base Year– 2020
  • CAGR– 8.6%
  • Largest Market– North America
  • Fastest Growing Market– Asia Pacific

Legionella Testing Market

  • The report on global Legionella Testing Market gives historical, current, and future market sizes (US$ Mn) on the basis of application, product, distribution channel and geography.
  • Legionella Testing Market report gives comprehensive outlook across the region with special emphasis on key regions such as North America, Europe, Asia Pacific, Latin America and Middle East and Africa.
Key Players
  • Merck Millipore (U.S)
  • Abbott laboratories (U.S)
  • Becton, Dickinson & Co. (U.S)
  • Beckman Coulter, Inc. (U.S)
  • Idexx Laboratories (U.S)
Dynamics

Legionella Testing Market

The growing necessity of water testing in numerous industries as a preventative measure for infectious diseases is expected to fuel the Legionella water testing market’s growth. Furthermore, the market’s expansion is due to developments in diagnostic technologies in terms of digitalization and automation. These tests, for example, can take several weeks to give precise results. During the projection period, the market for legionella testing is expected to increase slowly due to the delay in traditional testing methods.


North-America got significant share

Legionella Testing Market

Because of the rising number of patients with legionella infections and the existence of essential competitors in the region, North America has dominated the market. Additionally, the US government is raising public awareness about LD through the environmental legionella isolation techniques assessment (ELITE) program, which could boost the market's growth. Europe held the second-largest Legionella testing market share attributable to the growing adoption of high-cost PCR tests and increasing Legionella outbreaks in the region

Latin America
Latin-America
North-America
North-America
Europe
Europe
Asia Pacific
Asia-Pacific
Middle East
Middle East

Key

Features of the Report

  • The report provides granular level information about the market size, regional market share, historic market (2015-2020) and forecast (2021-2027)
  • The report covers in-detail insights about the competitor’s overview, company share analysis, key market developments, and their key strategies
  • The report outlines drivers, restraints, unmet needs, and trends that are currently affecting the market
  • The report tracks recent innovations, key developments and startup’s details that are actively working in the market
  • The report provides a plethora of information about market entry strategies, regulatory framework and reimbursement scenari0

Legionella Testing Market Segmentation


Location

GEOGRAPHY

Frequently Asked Questions

The Legionella Testing Market is projected to expand at a CAGR of 9.7% during the forecast period.

Abbott laboratories, Becton, Dickinson & Co., Beckman Coulter, Inc., Idexx Laboratories, Merck Millipore (U.S)

Asia-Pacific is the fastest-growing region for Legionella Testing Market


Report

Table Of Content


Report

Company Profile

  • Merck Millipore (U.S)
  • Abbott laboratories (U.S)
  • Becton, Dickinson & Co. (U.S)
  • Beckman Coulter, Inc. (U.S)
  • Idexx Laboratories (U.S)
  • Alere, Inc. (U.S)
  • Thermo Fischer Scientific, Inc. (U.S)
  • IDEXX (U.S)

Description

The legionella testing market is anticipated to be valued at USD 241.5 million in 2021 and is expanded to grow at a significant CAGR of 9.7% over 2022-2028. Legionella bacterial species are present in freshwater reservoirs and are responsible for legionnaire’s disease, a respiratory ailment. The market is anticipated to increase fast during the projected period due to the increased incidence and prevalence of this disease, pushing up demand for testing kits. Furthermore, the rising incidence of hospital-acquired legionella infection and increased testing frequency in these facilities due to stringent regulations will drive demand for such effective products in the near future. The presence of diverse species in water reservoirs like ponds, lakes, swimming pools, warm water showers, and commercial building water supply pipes is increasing health hazards. Exposure to legionellosis outbreaks increases the risk of morbidity and mortality. Thus, stringent monitoring of water reservoirs and the launch of rapid testing methods for onsite water testing are anticipated to promote Legionella testing market growth. In the Legionella Testing Market, the Urinary Antigen Test (UAT) Segment is Expected to Hold a Major Market Share. This test category is predicted to develop rapidly over the projection period due to distinct advantages such as detecting whole serogroups associated with legionella and quick testing. Due to the expensive cost of PCR procedures, their general application in the current economy is limited.

Recent Market Developments:

In December 2021, QUIDEL CORPORATION signs a definitive agreement to acquire ortho clinical diagnostics. Provides Quidel’s expansive point-of-care diagnostics portfolio with access to Ortho’s broad global reach across 130-plus countries, accelerating growth for Quidel’s existing product portfolio and providing exposure to new, emerging markets

In Feb 2019, bioMérieux, an in vitro diagnostics and food microbiology testing company, announced the acquisition of Invisible Sentinel. This newly acquired company, based in Philadelphia, develops, manufactures, and markets molecular diagnostic tools for the rapid, accurate and reliable detection of pathogens and spoilage organisms in food and beverage.

ASIA PACIFIC OFFICE

Precision Business Insights, 5th Floor, Mohan’s Elite, Opp : Bharat Petroleum Pump, Khanamet Road, Hitech City, Hyderabad – 500084

EUROPE OFFICE

Precision Business Insights, Kemp House, 152 – 160 City Road, London EC1V 2NX